STI
55
-3
DVA
76
-7
GWW
48
4
RHI
34
4
GD
66
2
FCX
57
5
DIS
64
3
XRAY
19
-9
IVZ
43
5
RIG
44
3
DD
67
11
GOOGL
74
2
KMI
53
3
INTC
35
3
GPC
56
2
SYF
97
2
PAYX
47
6
LEN
60
4
TXN
39
3
CLX
46
2
STI
55
-3
DVA
76
-7
GWW
48
4
RHI
34
4
GD
66
2
FCX
57
5
DIS
64
3
XRAY
19
-9
IVZ
43
5
RIG
44
3
DD
67
11
GOOGL
74
2
KMI
53
3
INTC
35
3
GPC
56
2
SYF
97
2
PAYX
47
6
LEN
60
4
TXN
39
3
CLX
46
2
Financhill
Back

iRhythm Technologies Vs. Oramed Pharmaceuticals Industry Stock Comparison

Sell
41

IRTC
iRhythm Technologies

Last Price:
102.64
Seasonality Move:
6.21%
Sell
33

ORMP
Oramed Pharmaceuticals

Last Price:
2.36
Seasonality Move:
6.12%
Sell
41
iRhythm Technologies (IRTC) is a Sell

Is iRhythm Technologies a Buy, Sell or Hold?

  • The current iRhythm Technologies [IRTC] share price is $102.68. The Score for IRTC is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • IRTC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Oramed Pharmaceuticals (ORMP) is a Sell

Is Oramed Pharmaceuticals a Buy, Sell or Hold?

  • The current Oramed Pharmaceuticals [ORMP] share price is $2.35. The Score for ORMP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • ORMP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IRTC Stock Price Chart

What is iRhythm Technologies's stock price today?

  • The iRhythm Technologies share price today is $102.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IRTC is experiencing selling pressure, which indicates risk of future bearish movement.

ORMP Stock Price Chart

What is Oramed Pharmaceuticals's stock price today?

  • The Oramed Pharmaceuticals share price today is $2.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORMP is experiencing selling pressure, which indicates risk of future bearish movement.

IRTC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.76 Sell
Relative Strength Index (14 RSI): 35.71 Sell
Chaikin Money Flow: -862128 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (108.51 - 114.61) Sell
Bollinger Bands (100): (104.57 - 117.17) Sell

ORMP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 41.7 Sell
Chaikin Money Flow: -64695 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.3 - 2.66) Sell
Bollinger Bands (100): (2.27 - 3.01) Sell

IRTC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 110.42 Sell
20-day SMA: 111.88 Sell
50-day SMA: 110.77 Sell
200-day SMA: 101.63 Buy
8-day EMA: 109.49 Sell
20-day EMA: 110.87 Sell
50-day EMA: 110.85 Sell
200-day EMA: 106.72 Sell

ORMP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.36 Sell
20-day SMA: 2.42 Sell
50-day SMA: 2.75 Sell
200-day SMA: 2.62 Sell
8-day EMA: 2.36 Sell
20-day EMA: 2.44 Sell
50-day EMA: 2.59 Sell
200-day EMA: 2.87 Sell

iRhythm Technologies Earnings Growth & IRTC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.06 per share, a decrease this year of $0.15 per share, and an increase next year of $1.26 per share.

Oramed Pharmaceuticals Earnings Growth & ORMP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.00 per share.

iRhythm Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Oramed Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):